Evidence map›Paper›PMID 26637829›Full record

ReviewActa biochimica et biophysica Sinica2016

Autophagy regulation in the development and treatment of breast cancer.

Yuting Zhou, Edmund B Rucker, Binhua P Zhou

Open access · greenAbstract readReview
In one paragraph

Review in Acta biochimica et biophysica Sinica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Prohibitin 2/PHB2 in Parkin-Mediated Mitophagy: A Potential Therapeutic Target for Non-Small Cell Lung Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Yuting ZhouDepartment of Molecular and Cellular Biochemistry, University of Kentucky School of Medicine, Lexington, KY 40506, USA Department of Markey Cancer Center, University of Kentucky School of Medicine, Lexington, KY 40506, USA.
Edmund B RuckerDepartment of Biology, University of Kentucky College of Arts and Sciences, Lexington, KY 40506, USA Department of Markey Cancer Center, University of Kentucky School of Medicine, Lexington, KY 40506, USA.
Binhua P ZhouDepartment of Molecular and Cellular Biochemistry, University of Kentucky School of Medicine, Lexington, KY 40506, USA Department of Markey Cancer Center, University of Kentucky School of Medicine, Lexington, KY 40506, USA peter.zhou@uky.edu.
Markey Cancer Center · USUniversity of Kentucky · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI KATHLEEN L. O'CONNOR · 2013 to 2026
$38.3M
Regulation of Snail in breast cancer progression and metastasisR01CA125454 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI ZHOU, BINHUA P · 2007 to 2017
$2.8M
Determine the Functional Role Dub3 in Breast Cancer Progression and MetastasisR01CA188118 · NCI · UNIVERSITY OF KENTUCKY · PI ZHOU, BINHUA P · 2015 to 2019
$1.7M
NCI NIH HHS P30 CA177558NCI NIH HHS R01 CA125454NCI NIH HHS R01 CA188118
6 · The paper itself

Abstract

Autophagy is a major catabolic process in which intracellular membrane structures, protein complexes, and lysosomes are formed as lysoautophagosome to degrade and renew cytoplasmic components. Autophagy is physiologically a strategy and mechanism for cellular homeostasis as well as adaptation to stress, and thus alterations in the autophagy machinery may lead to diverse pathological conditions. The role of autophagy in cancer is complex, and the current literature reflects this as a 'double-edged sword'. Autophagy shows promise as a novel therapeutic target in various types of breast cancer, inhibiting or increasing treatment efficacy in a context- and cell-type-dependent manner. This review aims to summarize the recent advances in the understanding of the mechanisms by which key modulators of autophagy participate in cancer metastasis, highlight different autophagy-deficient murine models for breast cancer study, and provide further impetus for the modulation of autophagy in anticancer therapy.

Indexed as

AutophagyGene Expression Regulation, NeoplasticAnimalsAntineoplastic AgentsBeclin-1Breast NeoplasmsCell SurvivalGenotypeHumansInflammationLysosomesMiceNeoplasm MetastasisPhenotypePhosphatidylinositol 3-KinasesSignal TransductionAntineoplastic AgentsBeclin-1BECN1 protein, humanPhosphatidylinositol 3-Kinasesautophagybreast cancermTOR

Identifiers

PMID26637829
PMCPMC4689162
OpenAlexW2195310352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.